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The demonstration of Mycobacterium tuberculosis DNA in ancient skeletons gives researchers an insight
into its evolution. Findings of the last two decades sketched the biological relationships between the
various species of tubercle bacilli, the time scale involved, their possible origin and dispersal. This paper
includes the available evidence and on-going research. In the submerged Eastern Mediterranean
Neolithic village of Atlit Yam (9000 BP), a human lineage of M. tuberculosis, deﬁned by the TbD1 deletion
in its genome, was demonstrated. An infected infant at the site provides an example of active tuber-
culosis in a human with a naïve immune system. Over 4000 years later tuberculosis was found in Jericho.
Urbanization increases population density encouraging M. tuberculosis/human co-evolution. As suscep-
tible humans die of tuberculosis, survivors develop genetic resistance to disease. Thus in 18th century
Hungarian mummies from Vac, 65% were positive for tuberculosis yet a 95-year-old woman had clearly
survived a childhood Ghon lesion.
Whole genome studies are in progress, to detect changes over the millennia both in bacterial virulence
and also host susceptibility/resistance genes that determine the NRAMP protein and Killer Cell
Immunoglobulin-like Receptors (KIRs). This paper surveys present evidence and includes initial ﬁndings.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Microbial infections played a key role in shaping life on earth
and have been a major selector for the evolution of all present
species. Evidence exists that demonstrate infectious diseases werePark, London NW1 4RD, UK.
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Gal), cmatheso@lakehead.caalready present in our remote ancestors [1,2]. Considering the
impact ofMycobacterium tuberculosis (MTB), in all probability it has
had a greater inﬂuence on the genetic selection of the Homo sapiens
population than any other infectious agent.
The molecular identiﬁcation of human pathogens in ancient hu-
man remains has recently opened new scientiﬁc ﬁelds that provide
considerable insight into the history and evolution of host, pathogen
and their interaction. This allows us to track changes in the ancestral
tubercle bacillus as it becamemore andmore exposed to the internal
environment and immune system of its human host. Conversely, it is
possible to track changes in the genes of the human population that
confer resistance or susceptibility to disease over time.
TB is related to population density [3], transmitted from human
to human living in close contact. However, the origin of the disease,
M. Spigelman et al. / Tuberculosis 95 (2015) S145eS149S146the earliest hosts of MTB and its evolution remain unclear. The
evolution of the bacteria cannot be considered in isolation. It is
important to realise how TB has inﬂuenced the human develop-
ment over the millennia, particularly our resistance/susceptibility
genes Figure 1. MTB experienced an evolutionary bottleneck when
it became an obligate pathogen and has a clonal relationship with
different human lineages [4]. Subsequent co-evolution has resulted
in the majority of TB infections being latent. In past eras of low
human population density, MTB adapted over time in response to
host-adaptive changes and vice versa. This process, which can be
deﬁned as mutualism, is a biological interaction between in-
dividuals of two different species where both individuals derive a
ﬁtness beneﬁt. As the host becomes more resistant, strains better
able to colonise the resistant host will predominate, thus starting
off another cycle. More virulent MTB strains will attack their human
host, killing the most susceptible and leaving the more resistant as
survivors. However, when human populations were sparse, this
could break the chain of transmission of the pathogen. The devel-
opment of antibiotics has shortened the mutualistic cycle signiﬁ-
cantly, but the combination of HIV co-infection, antimicrobial
therapy and increased global human population density is leading
to the emergence of some MTB strains that are both more trans-
missible but also more virulent [5].2. The impact of palaeomicrobiological investigations of
archaeological human material
2.1. Questions to be addressed
Archaeologists should seek to correlate research questions with
historical events. For example, did past invasions introduce new
pathogens, or more virulent strains of pathogens into susceptible
populations? Thousands of indigenous peoples in the Americas
died from exposure to European strains of MTB, measles and
smallpox [6]. Another possible scenario is that invaders may have
brought new pathogens with them on return to their place of
origin. A good example of this is the introduction by European
colonialists of venereal syphilis from South America.
A further question one has to ask is what was the genetic status
of Homo erectus or predecessor species regarding the underlyingFigure 1. Co-evolution between human and pathogens. Evolution of one species in
response to characteristics of another.genetic basis of host resistance and susceptibility to tuberculosis.
Did ancestral hominids have the precursors of modern host sus-
ceptibility/resistance genes or were these acquired late? Is the ‘Out
of Africa’ theory of the origin of human TB proposed by Gutierrez
et al. [7] capable of being veriﬁed by a study of human remains, or
will these show that TB developed in several areas and that this is
the explanation for the variability of the organism in different
geographical areas?
The majority of TB patients in the world today never progress to
active disease. The World Health Organisation estimates that
approximately one-third of the global population is infected but
only 10% of immunocompetent people progress to active disease
during their lifetime [8]. Our current immunity may be the result of
Darwinian selection only, or may depend upon whether particular
genes are switched on or off e a mechanism that can result in rapid
adaptation. It must be remembered that other non-genetic factors
inﬂuence human susceptibility to infection such as dietary de-
ﬁciencies, stress and trauma [9]. Long-term climatic changes have
an impact on vegetation and agriculture [10] whereas local varia-
tions in climate may inﬂuence transmission of MTB by infectious
aerosols. Temperature changes will determine whether humans
spend more time in the open air or enclosed spaces, for example.2.2. Signiﬁcant ﬁndings
With the ﬁrst reported ﬁnding of MTB DNA in ancient skeletons
based on ampliﬁcation of a small (123 bp) DNA target that was
speciﬁc for the MTB-complex [11] a new era of research into mi-
crobial pathogen evolution became possible. In addition to skeletal
remains, calciﬁed and mummiﬁed tissues also proved to be good
sources of MTB ancient DNA (aDNA)Mic [12]. Our knowledge was
enhanced with the ﬁnding of MTB in a 17000-year-old Pleistocene
bison from Natural Trap Cave, Wyoming [13]. Spoligotyping
revealed that the Pleistocene bison lesions contained aDNA from
the M. tuberculosis complex, possibly MTB or Mycobacterium afri-
canum, but distinct fromMycobacterium bovis. The consensus bison
spoligotyping pattern was compared with the combined database
collated by the National Institute of Public Health and Environment
(RIVM), Utrecht, The Netherlands and the Veterinary Science Di-
vision, Department of Agriculture and Rural Development, Belfast,
N. Ireland. No exact matches were found on the database. However,
in a computer analysis comparing a library of deﬁned species, the
highest similarity was from M. africanum (82.3%), then
M. tuberculosis e MTB (76.6%), with M. bovis having only 72.7%
similarity.
The original aDNA ﬁndings in the Pleistocene bison were
conﬁrmed ten years later by ﬁnding species-speciﬁc MTB cell wall
lipid biomarkers [14]. We have used this method of independent
conﬁrmation of our MTB aDNA ﬁndings since 1998 [15] because
lipid analysis uses methods based on the direct detection of fem-
togram quantities of target molecules, with no need for any
ampliﬁcation. This is a more rigorous method of independent
conﬁrmation than sending part of the specimen to another labo-
ratory for analysis.
The Pleistocene bison contained MTB-complex aDNA but the
particular lineage has not yet been identiﬁed. The earliest known
human MTB was detected and characterised in samples from the
submerged Neolithic site of Atlit Yam, a 9000-year-old settlement
submerged in the sea off the coast of Haifa in Israel [16]. The
ﬁndings were conﬁrmed by lipid analysis and the preservation was
sufﬁciently good that it was possible to conﬁrm that the MTB had
experienced the TbD1 deletion, found only in human lineages. This
is of particular signiﬁcance as this was a Pre-Pottery site with the
earliest evidence of animal domestication in the Levant.
Table 2
Genotypes of the SLC11A1 gene found in Hungarian and Nubian Mammies.
Sample Allele Genotype M. tuberculosis infection
1 2/3 Heterozygote Positive chest
2 2/3 Heterozygote Positive chest
3 2 Homozygote Positive chest and abdomen
4 2 Homozygote Positive chest and abdomen
5 2 Homozygote Positive chest and abdomen
6 2/3 Heterozygote Positive right lung and abdomen
7 2 Homozygote Positive chest
8 2/3 Heterozygote Positive chest, abdomen and pluera
9 3 Homozygote Positive left chest, left lung, left pelvis
and abdominal wall
10 * Positive soft tissue, pleura, rib
11 3 Homozygote Not Infected
12 3 Homozygote Not Infected
13 3 Homozygote Not Infected
14 2/4 Heterozygote Unknown
15 3/4 Heterozygote Unknown
Allele 1(201 bp) ¼ A(CA)5TG(CA)5TG(CA)11C; Allele
2(199 bp) ¼ A(CA)5TG(CA)5TG(CA)10C; Allele 3 (197 bp) ¼ A(CA)5TG(CA)5TG(CA)9C;
Allele 4(199 bp) ¼ A(CA)5TG(CA)9C.
* Mutation present e to be conﬁrmed.
Table 1
The SLC11A1 gene promoter microsatellite primer set.
Primer Sequence
C1 ACT CGC ATT AGG CCA ACG AG
C2(FAM)* (6FAM) TTC TGT GCC TCC CAA GTT AGC
The primer was published by Bellamy et al., 1998 [25].
* The antisense primer marked with ﬂorescent dye.
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collections of natural mummies e one from the 18th to early 19th
century from Vac, Hungary and the second from early Christian
Nubia dated to 500e1400 CE at Kulubnarti in Northern Sudan. The
importance of these collections was that the DNA preservation is
well above average as in both locations the bodies were naturally
mummiﬁed with no chemicals used. Indeed, the Kulubnarti ma-
terial demonstrated co-infections of MTB with Leishmania spp, and
using the Hungarian material, it was possible to determine the
main MTB genetic lineages and perform molecular typing [17]. Our
work on the Pleistocene bison together with the Hungarian Vac
mummies was cited and assisted in developing the hypothesis
proposed in an excellent early paper on MTB evolution by Brosch
et al. [18]
To ﬁll the time gap between the Nubian Kulubnarti mummies
and the Attlit Yam skeletal remains, specimens from the Bronze Age
township of Jericho have been examined. Initially bones from early
excavations from the 1950's were studied, in a collaboration
involving colleagues from Munich, Al Quds University and Jerusa-
lem. Unfortunately, although these specimens yielded possible
MTB aDNA, this could not be conﬁrmed independently. Material
from the excavation of Ain es-Sultan refugee camp area, where
ancient Jericho (Tel es-sultan) ~4000 BC has yielded MTB aDNA,
which has been conﬁrmed by lipid analysis. The infecting pathogen
was from a TbD1-deleted MTB lineage. At present a metagenomic
study on this specimen is in progress at McMasters University.
The Hungarian mummy project based on 265 bodies, most
wholly or partially mummiﬁed, from a sealed crypt, is unique as
there is contemporaneous archival information about many of the
individuals. This enabled the identiﬁcation of some family groups
and also made it possible to study TB in a large population from a
ﬁxed period and single location [12]. It was possible to type the MTB
aDNA within a family and to show that each member was infected
with a slightly different strain [17]. Recently, lung tissue from the
older daughter in this family group has been shown by non-enriched
whole genome sequencing, to contain two different strains of MTB,
with apparent sequential deletions, that appear to be ancestral to a
modern outbreak strain in Germany [19]. In contrast, MTB aDNAwas
found in a calciﬁed lymph node from the mediastinum of a 95-year-
old mummy, where initially all tissues were negative but an X-ray
showed the calciﬁed node. This demonstrates that in this well-
preserved group of mummies it is possible to identify cases of
active and of latent infection [20]. It was these ﬁnding that led to our
interest in host susceptibility and resistance genes.
3. Host susceptibility and resistance
In addition to the retrieval of the pathogen DNA, a pilot study is
investigating the genes believed to be responsible for susceptibility
or resistance to the disease to determine if these genes differ in any
way between those who were infected and those who appear im-
mune. The study of the host susceptibility/resistance factors in the
mummies and their descendants will give information on the role
of host genetics in the pathogenesis of infectious disease, and
contribute to the design of new therapeutic strategies. The study
involves two host targets, the SLC11A1 gene (previously named
NRAMP) and Killer Cell Immunoglobulin-like Receptors (KIRs)
genes. The plan is to seek any correlation between presence and
absence of tuberculosis, with the presence of certain alleles in these
resistance genes. Already, our initial research on material from
Hungarian and Sudanese mummies has revealed some interesting
genetic patterns Table 1.
KIRs are members of a group of regulatory molecules found on
subsets of lymphoid cells, ﬁrst identiﬁed by their ability to impart
some speciﬁcity on natural killer (NK) cytolysis. The KIR locus,which maps to chromosome 19q(13.4) within the 1 Mb Leukocyte
Receptor Complex (LRC), contains a family of polymorphic and
highly homologous genes. KIR genes are tandemly arrayed over a
physical distance of about 150 Kb, displaying the remarkable
feature of gene content variation among haplotypes. The KIR mol-
ecules recognize the Human Leukocyte Antigen (HLA) class I mol-
ecules, which are encoded by genes within the Major
Histocompatibility Complex (MHC) chromosome 6 [21]. In-
teractions between KIR isotypes that inhibit natural killer (NK) cell
activity and speciﬁc HLA class I allotypes protect healthy cells from
spontaneous destruction by NK cell mediated cytolysis. Other KIR
isotypes stimulate the activity of NK cells demonstrating that KIR
play a signiﬁcant role in the control of the innate immune response.
Recent studies report a greater repertoire of inhibitory KIR genes
among TB patients than controls [22] and a direct association of
certain KIR and HLA-C genes [23] with resistance to pulmonary TB.
Different KIR genes have a role in inhibiting or increasing suscep-
tibility towards TB and the complimentary MHC ligands need to be
tested for the functional relevance of the associated genes [24].
A contemporaneous study of the SLC11A1 gene is in progress at
Lake Head University. The promoter region has been studied in
modern populations and been linked to a number of infections and
autoimmune diseases, caused by M. tuberculosis, M. bovis, Myco-
bacterium leprae, Mycobacterium lepraemurium, Salmonella typhi-
murium and Leishmania donovani. The identiﬁcation of sequence
variants has prompted research into the evolution of nuclear genes,
inheritance patterns, selective pressures, and changes in both allele
frequencies and disease linkages over time. Linkage studies can
help ascertain the resistance and susceptibility factors of diseases
and can assist modern medicine by providing a better under-
standing of the infectious processes themselves [25,26]. The Allele
2 variation of the promoter regionwas found to be present in every
patient infected with tuberculosis, indicating that this level of
allelic expression may well be related to the resistance or
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to produce the highest level of SLC11A1 expression, which confers a
resistance to microbial infection to the individual, but increases
susceptibility to autoimmune diseases. Conversely, Allele 2 pro-
duces the lowest level of SLC11A1 expression, conferring individual
resistance to autoimmune diseases, but also a greater susceptibility
tomicrobial infections. It is possible that this contradiction in allelic
expressions may have resulted from inverse selective pressures,
serving to maintain both alleles within the human population.
Allelic variants of SLC11A1 have been identiﬁed as risk factors for
paediatric TB [27]. Other studies of host susceptibility and resis-
tance genes have indicated that different human lineages may
exhibit differing susceptibilities to TB infection [28]. There is also
limited evidence that genetic expression may vary according to sex
and age [29]. An intriguing ﬁnding is that human genetic suscep-
tibility varies according to the differing clinical forms of TB [30].
Limited data are now available on ampliﬁed aDNA from 18 in-
dividuals from 18th century Vac, Hungary and early Christian Nubia
(Table 2) [25]. The promoter microsatellite polymorphisms of the
SLC11A1 gene look encouraging as patterns are emerging (Table 2).
Both the KIR and SLC11A1 studies are on-going and results will be
disclosed on completion.
4. Conclusions
This study seeks to show the progress that has been achieved in
paleomicrobiological research over the last two decades and in-
dicates its contribution to the study of human pathogen co-
evolution. Understanding the adaptations that the host and the
pathogen have undergone through history, together with the
resistance/susceptibility adaptations, may shed light on future in-
teractions of humans with MTB. It is highly important to under-
stand the process of mutualism e the biological interaction
between individuals of two different species, where each derives a
ﬁtness beneﬁt e in the present era of personalized medicine.
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